Technology • Semiconductors & AI Accelerators • SIC 3674
$204.64 ▼ -9.02
(-4.22%)
MKT CAP: $4.98T • VOL: 165.92M
52W L $164 52W H $243
NVDA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2026
FILED 2026-02-25 | FY 2025
FILED 2026-02-25 | FY 2024
FILED 2026-02-25 | FY 2023
FILED 2025-02-26 | FY 2022
FILED 2024-02-21 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $215.94B | $130.50B | $60.92B | $26.97B | $26.91B |
| YoY Revenue Growth % | +65.5% | +114.2% | +125.8% | +0.2% | +61.4% |
| Gross Profit | $153.46B | $97.86B | $44.30B | $15.36B | $17.48B |
| Gross Margin % | 71.1% | 75.0% | 72.7% | 56.9% | 64.9% |
| Research & Development (R&D) | $18.50B | $12.91B | $8.68B | $7.34B | $5.27B |
| Operating Income (EBIT) | $130.39B | $81.45B | $32.97B | $4.22B | $10.04B |
| Operating Margin % | 60.4% | 62.4% | 54.1% | 15.7% | 37.3% |
| Net Income (GAAP) | $120.07B | $72.88B | $29.76B | $4.37B | $9.75B |
| EBITDA (Normalized) | $133.23B | $83.32B | $34.48B | $5.77B | $11.21B |
| Diluted EPS ($/sh) | $4.90 | $2.94 | $1.19 | $0.17 | $3.85 |
| Operating Cash Flow (OCF) | $102.72B | $64.09B | $28.09B | $5.64B | $9.11B |
| Capital Expenditures (CapEx) | $6.04B | $3.24B | $1.07B | $1.83B | $976.0M |
| Free Cash Flow (FCF) | $96.68B | $60.85B | $27.02B | $3.81B | $8.13B |
| FCF Margin % | 44.8% | 46.6% | 44.4% | 14.1% | 30.2% |
| Return on Invested Capital (ROIC %) | 66.4% | 81.3% | 57.4% | 11.3% | 22.3% |
| Cash & Short-Term Equivalents | $10.61B | $8.59B | $7.28B | $3.39B | $1.99B |
| Total Debt (Short + Long Term) | $8.47B | $8.46B | $9.71B | $10.95B | $10.95B |
| Total Stockholders' Equity | $157.29B | $79.33B | $42.98B | $22.10B | $26.61B |
| LINE ITEM (USD / %) | Q2 2027
FILED 2026-08-26 | Q1 2027
FILED 2026-05-20 | Q4 2026
FILED 2026-02-25 | Q3 2026
FILED 2025-11-19 | Q2 2026
FILED 2026-08-26 | Q1 2026
FILED 2026-05-20 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $96.22B | $81.61B | $68.13B | $57.01B | $46.74B | $44.06B |
| YoY Revenue Growth % | +105.8% | +85.2% | +73.2% | +62.5% | +55.6% | +69.2% |
| Gross Profit | $72.14B | $61.16B | $51.09B | $41.85B | $33.85B | $26.67B |
| Gross Margin % | 75.0% | 74.9% | 75.0% | 73.4% | 72.4% | 60.5% |
| Research & Development (R&D) | $7.05B | $6.32B | $5.51B | $4.71B | $4.29B | $3.99B |
| Operating Income (EBIT) | $63.73B | $53.54B | $44.30B | $36.01B | $28.44B | $21.64B |
| Operating Margin % | 66.2% | 65.6% | 65.0% | 63.2% | 60.8% | 49.1% |
| Net Income (GAAP) | $59.69B | $58.32B | $42.96B | $31.91B | $26.42B | $18.77B |
| EBITDA (Normalized) | $70.11B | $54.53B | $48.73B | $39.61B | $31.28B | $22.25B |
| Diluted EPS ($/sh) | $2.46 | $2.39 | $1.76 | $1.30 | $1.08 | $0.76 |
| Operating Cash Flow (OCF) | $24.08B | $50.34B | $36.19B | $23.75B | $15.37B | $27.41B |
| Capital Expenditures (CapEx) | $2.68B | $1.76B | $1.28B | $1.64B | $1.90B | $1.23B |
| Free Cash Flow (FCF) | $21.40B | $48.59B | $34.90B | $22.11B | $13.47B | $26.19B |
| FCF Margin % | 22.2% | 59.5% | 51.2% | 38.8% | 28.8% | 59.4% |
| Return on Invested Capital (ROIC %) | 84.0% | 88.7% | 90.2% | 98.2% | 92.7% | 88.7% |
| Cash & Short-Term Equivalents | $22.44B | $13.24B | $10.61B | $11.49B | $11.64B | $15.23B |
| Total Debt (Short + Long Term) | $33.37B | $8.47B | $8.47B | $8.47B | $8.47B | $8.46B |
| Total Stockholders' Equity | $228.98B | $195.47B | $157.29B | $118.90B | $100.13B | $83.84B |